当前位置: 首页 > 期刊 > 《世界中医药》 > 20202
编号:13516638
基于中医经典理论探索新型冠状病毒肺炎治疗策略及麻黄升麻汤为主方的可行性分析(6)
http://www.100md.com 2020年1月15日 《世界中医药》 20202
     [24]Man Lung YEUNG,Yamina BENNASSER,Shu Yun LE,et al.siRNA,miRNA and HIV:promises and challenges[J].Cell Resecarch,2005,15(11-12):935-946.

    [25]Canton J,Fehr AR,Fernandez-Delgado R,et al.MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection[J].PLoS Pathog,2018,14(1):e1006838.

    [26]Lee JY,Bae S,Myoung J.Middle East Respiratory Syndrome Coronavirus-Encoded Accessory Proteins Impair MDA5-and TBK1-Mediated Activation of NF-κB[J].J Microbiol Biotechnol,2019,29(8):1316-1323.

    [27]Totura AL,Whitmore A,Agnihothram S,et al.Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection[J].mBio,2015,6(3):e00638-15.

    [28]Gralinski LE,Menachery VD,Morgan AP,et al.Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice[J].G3(Bethesda),2017,7(6):1653-1663.

    (2020-02-12收稿 責任编辑:王明), http://www.100md.com(杨涛 崔人匀 刘寰宇 郝力争 陈健 安炯俊 李忠)
上一页1 2 3 4 5 6